Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
AMLX on Nasdaq
James M. Frates - trading volume in the past year for Amylyx Pharmaceuticals, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
291K |
$1.01M |
$3.47 |
Mar 31, 2025 |
Direct |
|
|
| Common Stock |
11.1K |
$38.4K |
$3.47 |
Mar 31, 2025 |
By Trust |
|
|
| Stock Option (right to buy) |
103K |
|
|
Mar 6, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.